To further strengthen its links with academia, Chelsea Technologies Group is delighted to be a partner on Oxford University's Industrial Doctorate in Systems Approaches to Biomedical Science (SABS-IDC) programme. This innovative 4-year Doctorate Programme is an EPSRC-led initiative designed to ensure that the UK has a strong pipeline of future innovators and research leaders in the UK pharmaceutical, biomedical, biotechnology, and biomedically-related IT sectors.

SABS-IDC aims to integrate academic and industrial approaches to research. To this end it operates in collaboration with all relevant departments at Oxford University and with a wide range of Industrial Partners. Chelsea Technologies Group is one of these partners.

"Chelsea has a long tradition of working with academic centres of excellence and we strongly support the aims of Oxford University's programme," said Dr John Attridge, Technical Director at Chelsea Technologies. "The collaboration will fuse Oxford University's expertise in single molecule detection techniques with our commercial experience in the development of fluorescence based analytical instrumentation."

Tags: Chelsea Technologies Group